{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:34:59Z","timestamp":1793061299662,"version":"4.5.0"},"reference-count":88,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T00:00:00Z","timestamp":1782432000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA281735"],"award-info":[{"award-number":["R01CA281735"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA257623"],"award-info":[{"award-number":["R01CA257623"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Institutes of Health National Cancer Institute","doi-asserted-by":"publisher","award":["R33CA277820"],"award-info":[{"award-number":["R33CA277820"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports Medicine"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.xcrm.2026.102938","type":"journal-article","created":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T14:57:04Z","timestamp":1784818624000},"page":"102938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Driving tumor-associated macrophages to a CXCL9Hi\/SPP1Low phenotype eliminates pancreatic cancer"],"prefix":"10.1016","volume":"7","author":[{"given":"Yen T.M.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pfefferl\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhyun","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant G.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sierra A.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Noguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher S.","family":"Garris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riley J.","family":"Deutsch-Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratyaksha","family":"Wirapati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"De Stefano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Goemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rui","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Vinegoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Fern\u00e1ndez del Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S.","family":"Liss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikael J.","family":"Pittet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0828-4143","authenticated-orcid":false,"given":"Ralph","family":"Weissleder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.xcrm.2026.102938_bib1","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1093\/jnci\/djab131","article-title":"Annual Report to the Nation on the Status of Cancer, Part 1: National Cancer Statistics","volume":"113","author":"Islami","year":"2021","journal-title":"J Natl Cancer Inst."},{"key":"10.1016\/j.xcrm.2026.102938_bib2","doi-asserted-by":"crossref","first-page":"4251","DOI":"10.1002\/cncr.34479","article-title":"Annual report to the nation on the status of cancer, part 1: National cancer statistics","volume":"128","author":"Cronin","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/j.xcrm.2026.102938_bib3","article-title":"Advances in pancreatic cancer early diagnosis, prevention, and treatment: The past, the present, and the future","volume":"76","author":"Mannucci","year":"2026","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.xcrm.2026.102938_bib4","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1097\/SLA.0000000000002234","article-title":"Patterns, Timing, and Predictors of Recurrence Following Pancreatectomy for Pancreatic Ductal Adenocarcinoma","volume":"267","author":"Groot","year":"2018","journal-title":"Ann. Surg."},{"key":"10.1016\/j.xcrm.2026.102938_bib5","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa1304369","article-title":"Increased survival in pancreatic cancer with nab-paclitaxel plus gemcitabine","volume":"369","author":"Von Hoff","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib6","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMoa1011923","article-title":"FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer","volume":"364","author":"Conroy","year":"2011","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib7","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/s41565-021-00897-1","article-title":"Therapeutically reprogrammed nutrient signalling enhances nanoparticulate albumin bound drug uptake and efficacy in KRAS-mutant cancer","volume":"16","author":"Li","year":"2021","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.xcrm.2026.102938_bib8","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.ejca.2018.12.007","article-title":"NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors","volume":"108","author":"Wang-Gillam","year":"2019","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.xcrm.2026.102938_bib9","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1038\/s41588-024-01890-9","article-title":"Spatially resolved analysis of pancreatic cancer identifies therapy-associated remodeling of the tumor microenvironment","volume":"56","author":"Shiau","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2026.102938_bib10","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/j.cell.2023.02.014","article-title":"Pancreatic cancer: Advances and challenges","volume":"186","author":"Halbrook","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib11","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1016\/j.immuni.2019.03.009","article-title":"Single-Cell Transcriptomics of Human and Mouse Lung Cancers Reveals Conserved Myeloid Populations across Individuals and Species","volume":"50","author":"Zilionis","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102938_bib12","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1126\/science.ade2292","article-title":"CXCL9:SPP1 macrophage polarity identifies a network of cellular programs that control human cancers","volume":"381","author":"Bill","year":"2023","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102938_bib13","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","article-title":"A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer","volume":"27","author":"Bassez","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib14","doi-asserted-by":"crossref","first-page":"1177","DOI":"10.1016\/j.ccell.2025.05.009","article-title":"Tumor and immune reprogramming during immunotherapy in advanced renal cell carcinoma","volume":"43","author":"Bi","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib15","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.cell.2021.01.010","article-title":"A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells","volume":"184","author":"Cheng","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib16","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1038\/s41591-018-0337-7","article-title":"Neoadjuvant anti-PD-1 immunotherapy promotes a survival benefit with intratumoral and systemic immune responses in recurrent glioblastoma","volume":"25","author":"Cloughesy","year":"2019","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib17","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.ccell.2021.03.007","article-title":"Single-cell sequencing links multiregional immune landscapes and tissue-resident T cells in ccRCC to tumor topology and therapy efficacy","volume":"39","author":"Krishna","year":"2021","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib18","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41571-022-00620-6","article-title":"Clinical relevance of tumour-associated macrophages","volume":"19","author":"Pittet","year":"2022","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.xcrm.2026.102938_bib19","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12967-023-04688-1","article-title":"Potential crosstalk between SPP1 + TAMs and CD8 + exhausted T cells promotes an immunosuppressive environment in gastric metastatic cancer","volume":"22","author":"Du","year":"2024","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202303177","article-title":"NAMPT-Driven M2 Polarization of Tumor-Associated Macrophages Leads to an Immunosuppressive Microenvironment in Colorectal Cancer","volume":"11","author":"Hong","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102938_bib21","doi-asserted-by":"crossref","first-page":"7915","DOI":"10.1038\/s41467-023-43746-6","article-title":"Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment","volume":"14","author":"Li","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102938_bib22","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1038\/s41598-024-53207-9","article-title":"Identification of a novel macrophage-related prognostic signature in colorectal cancer","volume":"14","author":"Lin","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102938_bib23","doi-asserted-by":"crossref","first-page":"6619","DOI":"10.1038\/s41467-022-34395-2","article-title":"Pan-cancer single-cell analysis reveals the heterogeneity and plasticity of cancer-associated fibroblasts in the tumor microenvironment","volume":"13","author":"Luo","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102938_bib24","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41467-022-29366-6","article-title":"Single-cell and spatial analysis reveal interaction of FAP+ fibroblasts and SPP1+ macrophages in colorectal cancer","volume":"13","author":"Qi","year":"2022","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102938_bib25","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/s41698-023-00455-z","article-title":"High-dimensional deconstruction of pancreatic cancer identifies tumor microenvironmental and developmental stemness features that predict survival","volume":"7","author":"Storrs","year":"2023","journal-title":"npj Precis. Oncol."},{"key":"10.1016\/j.xcrm.2026.102938_bib26","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202410360","article-title":"Targeted SPP1 Inhibition of Tumor-Associated Myeloid Cells Effectively Decreases Tumor Sizes","volume":"12","author":"Kartal","year":"2025","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102938_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202309026","article-title":"Pharmacological Polarization of Tumor-Associated Macrophages Toward a CXCL9 Antitumor Phenotype","volume":"11","author":"Enbergs","year":"2024","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102938_bib28","doi-asserted-by":"crossref","DOI":"10.1002\/cmdc.202400416","article-title":"\u03b3-Butyrolactone Derivatives of MSA-2 are STING Prodrugs","volume":"19","author":"Schleyer","year":"2024","journal-title":"ChemMedChem"},{"key":"10.1016\/j.xcrm.2026.102938_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.bcp.2025.117120","article-title":"Dual inhibition of EGR1\/STAT3 transcriptional hubs suppresses macrophage-driven liver fibrosis: A multi-omics-guided drug repurposing strategy","volume":"240","author":"Mijit","year":"2025","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.xcrm.2026.102938_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.108072","article-title":"Irf1- and Egr1-activated transcription plays a key role in macrophage polarization: A multiomics sequencing study with partial validation","volume":"99","author":"Chu","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.xcrm.2026.102938_bib31","doi-asserted-by":"crossref","DOI":"10.1096\/fj.202403227R","article-title":"SPP1 macrophages across diseases: A call for reclassification?","volume":"39","author":"Reggio","year":"2025","journal-title":"FASEB J."},{"key":"10.1016\/j.xcrm.2026.102938_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41593-023-01257-z","article-title":"Perivascular cells induce microglial phagocytic states and synaptic engulfment via SPP1 in mouse models of Alzheimer\u2019s disease","volume":"26","author":"De Schepper","year":"2023","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.xcrm.2026.102938_bib33","doi-asserted-by":"crossref","first-page":"21526","DOI":"10.18632\/oncotarget.15630","article-title":"CD163 as a marker of M2 macrophage, contribute to predicte aggressiveness and prognosis of Kazakh esophageal squamous cell carcinoma","volume":"8","author":"Hu","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.xcrm.2026.102938_bib34","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12950-023-00360-z","article-title":"Advances in the study of macrophage polarization in inflammatory immune skin diseases","volume":"20","author":"Xia","year":"2023","journal-title":"J. Inflamm."},{"key":"10.1016\/j.xcrm.2026.102938_bib35","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.7150\/ijbs.91519","article-title":"TREM2 promotes macrophage polarization from M1 to M2 and suppresses osteoarthritis through the NF-\u03baB\/CXCL3 axis","volume":"20","author":"Fang","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.xcrm.2026.102938_bib36","article-title":"Single-cell RNA Sequencing Identified Novel Nr4a1+ Ear2+ Anti-Inflammatory Macrophage Phenotype under Myeloid-TLR4 Dependent Regulation in Anti-Glomerular Basement Membrane (GBM) Crescentic Glomerulonephritis (cGN)","volume":"9","author":"Chen","year":"2022","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102938_bib37","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1161\/CIRCRESAHA.111.253377","article-title":"NR4A1 (Nur77) deletion polarizes macrophages toward an inflammatory phenotype and increases atherosclerosis","volume":"110","author":"Hanna","year":"2012","journal-title":"Circ. Res."},{"key":"10.1016\/j.xcrm.2026.102938_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202519981","article-title":"Reprogramming M2b Macrophages via GPX1 Activation by Selenium Nanoparticles Attenuates Lupus Nephritis","volume":"13","author":"Lv","year":"2026","journal-title":"Adv. Sci."},{"key":"10.1016\/j.xcrm.2026.102938_bib39","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1038\/s41419-021-03544-8","article-title":"CTRP12 ameliorates atherosclerosis by promoting cholesterol efflux and inhibiting inflammatory response via the miR-155-5p\/LXR\u03b1 pathway","volume":"12","author":"Wang","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.xcrm.2026.102938_bib40","doi-asserted-by":"crossref","first-page":"1872","DOI":"10.3390\/ijms19071872","article-title":"PPAR\u03b3 Expression Is Diminished in Macrophages of Recurrent Miscarriage Placentas","volume":"19","author":"Kolben","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.xcrm.2026.102938_bib41","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s12950-015-0081-4","article-title":"The PPAR-\u03b3 antagonist GW9662 elicits differentiation of M2c-like cells and upregulation of the MerTK\/Gas6 axis: a key role for PPAR-\u03b3 in human macrophage polarization","volume":"12","author":"Zizzo","year":"2015","journal-title":"J. Inflamm."},{"key":"10.1016\/j.xcrm.2026.102938_bib42","doi-asserted-by":"crossref","first-page":"787","DOI":"10.3389\/fimmu.2020.00787","article-title":"Lipin-1 Contributes to IL-4 Mediated Macrophage Polarization","volume":"11","author":"Chandran","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102938_bib43","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s13046-025-03380-0","article-title":"Reduction of alternative polarization of macrophages by short-term activated hepatic stellate cell-derived small extracellular vesicles","volume":"44","author":"Sun","year":"2025","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102938_bib44","doi-asserted-by":"crossref","first-page":"7591","DOI":"10.1038\/s41598-017-07381-8","article-title":"The transcription factor MafB promotes anti-inflammatory M2 polarization and cholesterol efflux in macrophages","volume":"7","author":"Kim","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.xcrm.2026.102938_bib47","doi-asserted-by":"crossref","first-page":"12015","DOI":"10.1021\/acsnano.8b04338","article-title":"Quantitative Imaging of Tumor-Associated Macrophages and Their Response to Therapy Using 64Cu-Labeled Macrin","volume":"12","author":"Kim","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2026.102938_bib48","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1038\/nmat3780","article-title":"Imaging macrophages with nanoparticles","volume":"13","author":"Weissleder","year":"2014","journal-title":"Nat. Mater."},{"key":"10.1016\/j.xcrm.2026.102938_bib45","doi-asserted-by":"crossref","first-page":"20666","DOI":"10.1021\/acsnano.3c08034","article-title":"Highly Active Myeloid Therapy for Cancer","volume":"17","author":"Fredrich","year":"2023","journal-title":"ACS Nano"},{"key":"10.1016\/j.xcrm.2026.102938_bib46","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202208782","article-title":"Dual Immunostimulatory Pathway Agonism through a Synthetic Nanocarrier Triggers Robust Anti-Tumor Immunity in Murine Glioblastoma","volume":"35","author":"Lugani","year":"2023","journal-title":"Adv. Mater."},{"key":"10.1016\/j.xcrm.2026.102938_bib49","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.immuni.2018.06.006","article-title":"Tumor Cell-Intrinsic Factors Underlie Heterogeneity of Immune Cell Infiltration and Response to Immunotherapy","volume":"49","author":"Li","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102938_bib50","first-page":"717","article-title":"Induction and chemotherapeutic response of two transplantable ductal adenocarcinomas of the pancreas in C57BL\/6 mice","volume":"44","author":"Corbett","year":"1984","journal-title":"Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102938_bib51","doi-asserted-by":"crossref","DOI":"10.1038\/s41551-025-01533-2","article-title":"Targeting immunosuppressive myeloid cells via implant-mediated slow release of small molecules to prevent glioblastoma recurrence","author":"Kaiser","year":"2025","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.102938_bib52","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1038\/s41588-024-01914-4","article-title":"Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity","volume":"56","author":"Khaliq","year":"2024","journal-title":"Nat. Genet."},{"key":"10.1016\/j.xcrm.2026.102938_bib53","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ccr.2012.04.025","article-title":"Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer","volume":"21","author":"Bayne","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib54","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.ccr.2012.04.024","article-title":"Oncogenic Kras-induced GM-CSF production promotes the development of pancreatic neoplasia","volume":"21","author":"Pylayeva-Gupta","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib55","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.immuni.2017.07.014","article-title":"Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression","volume":"47","author":"Zhu","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102938_bib56","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.cell.2023.02.020","article-title":"Macrophages at the interface of the co-evolving cancer ecosystem","volume":"186","author":"Kloosterman","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib57","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","article-title":"Macrophages as tools and targets in cancer therapy","volume":"21","author":"Mantovani","year":"2022","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.xcrm.2026.102938_bib58","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.celrep.2018.03.131","article-title":"CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype","volume":"23","author":"Candido","year":"2018","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102938_bib59","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1146\/annurev-med-062518-045435","article-title":"CD40 Agonist Antibodies in Cancer Immunotherapy","volume":"71","author":"Vonderheide","year":"2020","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib60","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1038\/s41591-022-01829-9","article-title":"Sotigalimab and\/or nivolumab with chemotherapy in first-line metastatic pancreatic cancer: clinical and immunologic analyses from the randomized phase 2 PRINCE trial","volume":"28","author":"Padr\u00f3n","year":"2022","journal-title":"Nat. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib61","doi-asserted-by":"crossref","first-page":"4574","DOI":"10.1158\/1078-0432.CCR-21-1047","article-title":"Neoadjuvant Selicrelumab, an Agonist CD40 Antibody, Induces Changes in the Tumor Microenvironment in Patients with Resectable Pancreatic Cancer","volume":"27","author":"Byrne","year":"2021","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102938_bib62","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aau9240","article-title":"Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies","volume":"11","author":"Panni","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.xcrm.2026.102938_bib63","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-003005","article-title":"GB1275, a first-in-class CD11b modulator: rationale for immunotherapeutic combinations in solid tumors","volume":"9","author":"DeNardo","year":"2021","journal-title":"J. Immunother. Cancer"},{"key":"10.1016\/j.xcrm.2026.102938_bib64","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1158\/1078-0432.CCR-19-1868","article-title":"Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade","volume":"26","author":"House","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.xcrm.2026.102938_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2020.108115","article-title":"Baseline Frequency of Inflammatory Cxcl9-Expressing Tumor-Associated Macrophages Predicts Response to Avelumab Treatment","volume":"32","author":"Qu","year":"2020","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102938_bib66","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1016\/j.immuni.2023.06.017","article-title":"Hypoxic niches attract and sequester tumor-associated macrophages and cytotoxic T cells and reprogram them for immunosuppression","volume":"56","author":"Sattiraju","year":"2023","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102938_bib67","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1158\/2326-6066.CIR-21-0588","article-title":"Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer","volume":"10","author":"Mujal","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.xcrm.2026.102938_bib68","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/j.immuni.2025.06.006","article-title":"Mitochondrial complex IV remodeling in tumor-associated macrophages amplifies interferon signaling and promotes anti-tumor immunity","volume":"58","author":"Clark","year":"2025","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102938_bib69","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/s41551-018-0236-8","article-title":"TLR7\/8-agonist-loaded nanoparticles promote the polarization of tumour-associated macrophages to enhance cancer immunotherapy","volume":"2","author":"Rodell","year":"2018","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.xcrm.2026.102938_bib70","doi-asserted-by":"crossref","first-page":"36","DOI":"10.7150\/ntno.50185","article-title":"Macrophage imaging and subset analysis using single-cell RNA sequencing","volume":"5","author":"Arlauckas","year":"2021","journal-title":"Nanotheranostics"},{"key":"10.1016\/j.xcrm.2026.102938_bib71","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.addr.2016.05.023","article-title":"Imaging the pharmacology of nanomaterials by intravital microscopy: Toward understanding their biological behavior","volume":"113","author":"Miller","year":"2017","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.xcrm.2026.102938_bib72","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.cell.2023.02.032","article-title":"A neutrophil response linked to tumor control in immunotherapy","volume":"186","author":"Gungabeesoon","year":"2023","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib73","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/s41590-023-01475-4","article-title":"TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer","volume":"24","author":"Park","year":"2023","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.xcrm.2026.102938_bib74","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1016\/j.cell.2020.06.032","article-title":"Coupled scRNA-Seq and Intracellular Protein Activity Reveal an Immunosuppressive Role of TREM2 in Cancer","volume":"182","author":"Katzenelenbogen","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib75","doi-asserted-by":"crossref","first-page":"2610","DOI":"10.1158\/2159-8290.CD-23-0299","article-title":"Spatial and Temporal Mapping of Breast Cancer Lung Metastases Identify TREM2 Macrophages as Regulators of the Metastatic Boundary","volume":"13","author":"Yofe","year":"2023","journal-title":"Cancer Discov."},{"key":"10.1016\/j.xcrm.2026.102938_bib76","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1016\/j.cell.2020.07.013","article-title":"TREM2 Modulation Remodels the Tumor Myeloid Landscape Enhancing Anti-PD-1 Immunotherapy","volume":"182","author":"Molgora","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib77","doi-asserted-by":"crossref","first-page":"7099","DOI":"10.1016\/j.cell.2025.10.030","article-title":"Macrophage-targeted immunocytokine leverages myeloid, T, and NK cell synergy for cancer immunotherapy","volume":"188","author":"von Locquenghien","year":"2025","journal-title":"Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib78","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1016\/j.immuni.2018.09.024","article-title":"Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-\u03b3 and IL-12","volume":"49","author":"Garris","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102938_bib79","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/j.immuni.2019.04.010","article-title":"Intratumoral Activity of the CXCR3 Chemokine System Is Required for the Efficacy of Anti-PD-1 Therapy","volume":"50","author":"Chow","year":"2019","journal-title":"Immunity"},{"key":"10.1016\/j.xcrm.2026.102938_bib80","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.936129","article-title":"MuSyC dosing of adjuvanted cancer vaccines optimizes antitumor responses","volume":"13","author":"Taylor","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.xcrm.2026.102938_bib81","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.ccell.2025.02.014","article-title":"Targeting tumor monocyte-intrinsic PD-L1 by rewiring STING signaling and enhancing STING agonist therapy","volume":"43","author":"Song","year":"2025","journal-title":"Cancer Cell"},{"key":"10.1016\/j.xcrm.2026.102938_bib82","article-title":"NF-\u03baB activation enhances STING signaling by altering microtubule-mediated STING trafficking","volume":"42","author":"Zhang","year":"2023","journal-title":"Cell Rep."},{"key":"10.1016\/j.xcrm.2026.102938_bib83","doi-asserted-by":"crossref","first-page":"4584","DOI":"10.1038\/s41467-023-40312-y","article-title":"Chemically programmed STING-activating nano-liposomal vesicles improve anticancer immunity","volume":"14","author":"Chen","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.xcrm.2026.102938_bib84","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1038\/s41557-025-01930-9","article-title":"Tumour-specific STING agonist synthesis via a two-component prodrug system","volume":"17","author":"Hsu","year":"2025","journal-title":"Nat. Chem."},{"key":"10.1016\/j.xcrm.2026.102938_bib85","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba6098","article-title":"An orally available non-nucleotide STING agonist with antitumor activity","volume":"369","author":"Pan","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.xcrm.2026.102938_bib86","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1002\/cplu.202000496","article-title":"Development of High-Drug-Loading Nanoparticles","volume":"85","author":"Liu","year":"2020","journal-title":"ChemPlusChem"},{"key":"10.1016\/j.xcrm.2026.102938_bib87","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s40262-023-01225-7","article-title":"Pharmacokinetics and Pharmacodynamics of Ruxolitinib: A Review","volume":"62","author":"Appeldoorn","year":"2023","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.xcrm.2026.102938_bib88","doi-asserted-by":"crossref","first-page":"2512","DOI":"10.1200\/JCO.2021.39.15_suppl.2512","article-title":"BDB001, an intravenously administered toll-like receptor 7 and 8 (TLR7\/8) agonist, in combination with pembrolizumab in advanced solid tumors: Phase 1 safety and efficacy results","volume":"39","author":"Patel","year":"2021","journal-title":"J. Clin. Oncol."}],"container-title":["Cell Reports Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003551?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666379126003551?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T00:21:49Z","timestamp":1793060509000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666379126003551"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":88,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2666379126003551"],"URL":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102938","relation":{},"ISSN":["2666-3791"],"issn-type":[{"value":"2666-3791","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Driving tumor-associated macrophages to a CXCL9Hi\/SPP1Low phenotype eliminates pancreatic cancer","name":"articletitle","label":"Article Title"},{"value":"Cell Reports Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xcrm.2026.102938","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102938"}}